CSIMarket
 


Precipio inc   (PRPO)
Other Ticker:  
 
 

PRPO's Revenue Growth by Quarter and Year

Precipio Inc 's Revenue results by quarter and year




PRPO Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 4.33 2.39 2.44 1.94
III Quarter September 4.52 2.22 2.25 1.63
II Quarter June 3.53 2.36 2.34 1.31
I Quarter March 2.82 2.45 1.82 1.22
FY   15.20 9.42 8.85 6.10



PRPO Revenue fourth quarter 2023 Y/Y Growth Comment
Precipio inc achieved in the fourth quarter 2023, above Company average Revenue rise of 81.13% year on year, to $ 4.33 millions.

Looking into fourth quarter 2023 results within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue growth. While Precipio Inc ' s Revenue jump of 81.13% ranks overall at the positon no. 1731 in the fourth quarter 2023.




PRPO Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 81.13 % -2.05 % 25.77 % 181.16 %
III Quarter September 103.6 % -1.33 % 38.04 % 108.97 %
II Quarter June 49.58 % 0.85 % 78.63 % 39.36 %
I Quarter March 15.1 % 34.62 % 49.18 % 71.83 %
FY   61.35 % 6.44 % 45.08 % 95.51 %

Financial Statements
Precipio Inc 's fourth quarter 2023 Revenue $ 4.33 millions PRPO's Income Statement
Precipio Inc 's fourth quarter 2022 Revenue $ 2.39 millions Quarterly PRPO's Income Statement
New: More PRPO's historic Revenue Growth >>


PRPO Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -4.23 % 7.66 % 8.44 % 19.02 %
III Quarter September 28.05 % -5.93 % -3.85 % 24.43 %
II Quarter June 25.18 % -3.67 % 28.57 % 7.38 %
I Quarter March 17.99 % 0.41 % -6.19 % 76.81 %
FY (Year on Year)   61.35 % 6.44 % 45.08 % 95.51 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #253
Overall #1731

Revenue Y/Y Growth Statistics
High Average Low
124.96 % 13.55 % -158.16 %
(Jun 30 2019)   (Sep 30 2016)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #253
Overall #1731
Revenue Y/Y Growth Statistics
High Average Low
124.96 % 13.55 % -158.16 %
(Jun 30 2019)   (Sep 30 2016)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Precipio Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
113.98 % 8.31 % -52.75 %
(Jun 30 2016)  


PRPO's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2023 Precipio Inc reported fall in Revenue sequentially by -4.23% to $ 4.33 millions, from $ 4.52 millions released in the previous reporting period.

Even cyclical influence which normally energize IV. Quarter 2023 performance, it clearly could not be enough to recover Laboratory Analytical Instruments's company IV. Quarter performance, Holly  Roberts, Healthcare sector veteran situated in Houston pointed out and wrote that average sequential Revenue growth is at 8.31% for PRPO.

Within Laboratory Analytical Instruments industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 1966.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #12
Healthcare Sector #308
Overall #1966
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #12
Healthcare Sector #308
Overall #1966
Revenue Q/Q Growth Statistics
High Average Low
113.98 % 8.31 % -52.75 %
(Jun 30 2016)  


PRPO's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2023 Precipio Inc disclosed fall in Revenue from the third quarter by -4.23% to $ 4.33 millions, from $ 4.52 millions achived in the previous quarter.

Although periodic factors which usually energize IV. Quarter 2023 results, this simply was not enough to rescue PRPO's IV. Quarter outcome, Holly  Roberts, Healthcare sector veteran situated in Houston pointed out and continued that average quarter on quarter Revenue growth is at 8.31% for Precipio Inc .

Within Laboratory Analytical Instruments industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 1966.


Precipio Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 15.20 $ 13.26 $ 10.96 $ 9.78 $ 9.41
Y / Y Revenue Growth (TTM) 61.46 % 40.22 % 15.48 % 3.27 % 6.36 %
Year on Year Revenue Growth Overall Ranking # 1213 # 1173 # 822 # 567 # 474
Seqeuential Revenue Change (TTM) 14.62 % 21.02 % 12 % 3.93 % -0.47 %
Seq. Revenue Growth (TTM) Overall Ranking # 1731 # 2257 # 2184 # 1981 # 1963




Cumulative Revenue growth Comment
Precipio Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 61.46% year on year, to $ 15 millions if the fiscal year would have ended in Dec 31 2023.
Precipio Inc 's trailing twelve months Revenue growth was higher than company's average 13.55% and higher than 40.22% growth in Sep 30 2023.
But from the previous reporting period increase was less at 14.62 % from $13.26 millions reported in the period from Sep 30 2023 to Dec 31 2022 Holly  Roberts went on.
In spite of, this was confirmation of strength, while the typical Q/Q TTM Revenue growth stands at 13.55%.
The growth was much stronger from the previous reporting period clinched at 14.62 % rise from $13.26 millions in the period from Sep 30 2023 to Dec 31 2022.

In the Healthcare sector 199 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1173 to 1213.

Revenue TTM Q/Q Growth Statistics
High Average Low
124.96 %
13.55 %
-158.16 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 200
Overall # 1213

Revenue TTM Y/Y Growth Statistics
High Average Low
124.96 %
13.55 %
-158.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 253
S&P 500 # 1731
Cumulative Revenue growth Comment
Precipio Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 61.46% year on year, to $ 15 millions if the fiscal year would have ended in Dec 31 2023.
Precipio Inc 's trailing twelve months Revenue growth was higher than company's average 13.55% and higher than 40.22% growth in Sep 30 2023.
But sequential rise was slower at 14.62 % from $13.26 millions reported in the period from Sep 30 2023 to Dec 31 2022.
Still it was confirmation of convincing trend, as the typical Q/Q TTM gain lays at 13.55%.
The growth was much more impressive from the previous reporting period clinched at 14.62 % increase from $13.26 millions in twelve months ending a quarter before.

In the Healthcare sector 199 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1173 to 1213.

Revenue TTM Q/Q Growth Statistics
High Average Low
124.96 %
13.55 %
-158.16 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 200
Overall # 1213

Revenue TTM Y/Y Growth Statistics
High Average Low
124.96 %
13.55 %
-158.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 253
S&P 500 # 1731




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRPO's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PRPO's Competitors
Revenue Growth for Precipio Inc 's Suppliers
Revenue Growth for PRPO's Customers

You may also want to know
PRPO's Annual Growth Rates PRPO's Profitability Ratios PRPO's Asset Turnover Ratio PRPO's Dividend Growth
PRPO's Roe PRPO's Valuation Ratios PRPO's Financial Strength Ratios PRPO's Dividend Payout Ratio
PRPO's Roa PRPO's Inventory Turnover Ratio PRPO's Growth Rates PRPO's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Intelgenx Technologies Corp 141.04%$ 141.040 millions
Co diagnostics Inc 140.48%$ 140.476 millions
Aclaris Therapeutics Inc 126.62%$ 126.622 millions
Globus Medical Inc 124.60%$ 124.604 millions
Sanuwave Health Inc 124.26%$ 124.259 millions
Roivant Sciences Ltd 117.80%$ 117.804 millions
Intelligent Bio Solutions Inc 114.22%$ 114.216 millions
Scisparc Ltd 113.73%$ 113.734 millions
Pacific Biosciences Of California Inc 113.62%$ 113.622 millions
Docgo Inc 112.37%$ 112.366 millions
Ionis Pharmaceuticals Inc112.32%$ 112.319 millions
Encompass Health Corporation109.55%$ 109.546 millions
Xencor Inc106.80%$ 106.798 millions
Volitionrx Limited103.79%$ 103.795 millions
Innovative Eyewear Inc 103.16%$ 103.159 millions
Coherus Biosciences inc 101.81%$ 101.808 millions
Palatin Technologies Inc 98.18%$ 98.176 millions
Hutchmed china Limited96.52%$ 96.525 millions
Adagene Inc 94.90%$ 94.900 millions
Sunshine Biopharma Inc 91.43%$ 91.425 millions
Immunitybio inc 90.41%$ 90.411 millions
Alimera Sciences Inc 89.98%$ 89.978 millions
Procept Biorobotics Corporation83.65%$ 83.652 millions
Ptc Therapeutics inc 83.41%$ 83.412 millions
Catalyst Pharmaceuticals Inc 81.98%$ 81.984 millions
Precipio inc 81.05%$ 81.054 millions
Bioadaptives Inc 80.75%$ 80.748 millions
Enovis Corporation79.22%$ 79.224 millions
Harrow Inc 76.01%$ 76.015 millions
Abeona Therapeutics Inc 74.00%$ 74.005 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com